40-Year-Old Woman Presents With Several Liver Nodules

Poll

A 40-year-old woman is found to have several nodules in the liver. After further evaluation, a biopsy is performed. What is your diagnosis?

A 40-year-old woman is found to have several nodules in the liver. According to the histopathology image below, what is your diagnosis?

What is your diagnosis?

A. Metastatic adenocarcinoma
B. Epithelioid hemangioendothelioma
C. Hepatocellular carcinoma
D. Hepatic adenoma
Recent Videos
3 experts in this video
3 experts in this video
3 experts in this video
3 experts in this video
Related Content
EC Approved Liso-cel in Pretreated Relapsed/Refractory Follicular Lymphoma

EC Approved Liso-cel in Pretreated Relapsed/Refractory Follicular Lymphoma

Tim Cortese
March 14th 2025
Article

Liso-cel has been approved by the European Commission for the treatment of adult patients with follicular lymphoma who received 2 or more prior lines of systemic therapy.

Oncologists Reflect on Pandemic's Lasting Impact on Cancer Care

Oncologists Reflect on Pandemic's Lasting Impact on Cancer Care

Aditya Bardia, MD, MPH;Ritu Salani, MD;Scarlett Lin Gomez, PhD;Marwan G. Fakih, MD;Elizabeth Ren Zhang-Velten, MD, PhD;Frances Chow, MD;James B. Yu, MD, MHS, FASTRO
March 10th 2025
Podcast

Hear from leading cancer experts about the lasting impact the COVID-19 pandemic has left on clinical practice.

Durvalumab Is Not Statistically Significant Vs Cetuximab in HNSCC

Durvalumab Is Not Statistically Significant Vs Cetuximab in HNSCC

Ariana Pelosci
March 13th 2025
Article

The trial was terminated early due to no statistical significance observed between durvalumab and cetuximab for patients with head and neck squamous cell carcinoma.

Traversing the Complexities of Non-Clear Cell Renal Cell Carcinoma

Traversing the Complexities of Non-Clear Cell Renal Cell Carcinoma

Manojkumar Bupathi, MD, MS;Benjamin Garmezy, MD;Stephanie A. Berg, DO
March 7th 2025
Podcast

A brief overview of the current RCC landscape was provided in the most recent Oncology Decoded podcast.

The 2025 SGO meeting will feature readouts of potentially impactful trial data in ovarian cancer, cervical cancer, and other gynecologic malignancies.

A Glimpse at Practice-Shifting Presentations at The 2025 SGO Annual Meeting

Russ Conroy
March 13th 2025
Article

The 2025 SGO meeting will feature readouts of potentially impactful trial data in ovarian cancer, cervical cancer, and other gynecologic malignancies.

New Cohort Approved in Phase 1/2 Trial of TTX-MC138 in Solid Cancers

New Cohort Approved in Phase 1/2 Trial of TTX-MC138 in Solid Cancers

Tim Cortese
March 13th 2025
Article

Based on positive safety data from the third cohort, a safety review committee approved the opening of a fourth cohort as well as more enrollment into the third cohort.